Malhotra Pooja, Aloman Costica, Ankireddy Aparna, Khadra Hani, Ooka Kohtaro, Gill Ravinder K, Saksena Seema, Dudeja Pradeep K, Alrefai Waddah A
Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois; and.
Rush University Medical Center, Chicago, Illinois.
Am J Physiol Gastrointest Liver Physiol. 2017 Nov 1;313(5):G376-G385. doi: 10.1152/ajpgi.00174.2017. Epub 2017 Aug 3.
Nonalcoholic fatty liver disease (NAFLD) is characterized by lipid accumulation in the liver that may progress to hepatic fibrosis and nonalcoholic steatohepatitis (NASH). Mechanisms underlying NAFLD and NASH are not yet fully understood. Dietary cholesterol was recently shown to be a risk factor for the development of NASH, suggesting a role for intestinal handling of cholesterol. One important regulator of cholesterol homeostasis is the sterol response element-binding protein-2 (SREBP-2) transcription factor. We tested the hypothesis that the overactivation of intestinal SREBP-2 increases the susceptibility to diet-induced NASH. A transgenic mouse model with intestine-specific overexpression of active SREBP-2 (ISR2 mice) driven by villin promoter was used. ISR2 mice and their wild-type littermates were fed a regular chow diet or a high-fat, high-cholesterol (HFHC) diet (15% fat, 1% cholesterol) for 15 wk. Results showed that HFHC feeding to ISR2 mice caused hepatic inflammation with increased levels of proinflammatory cytokines. Histological examination demonstrated extensive fibrosis after a HFHC diet associated with a perivascular as well as pericellular collagen deposits in ISR2 mice compared with wild-type littermates. The severe hepatic inflammation and advanced fibrosis in ISR2 mice was not associated with a difference in lipid accumulation in ISR2 mice compared with wild type littermates after HFHC feeding. These data indicate that overactivation of intestinal SREBP2 promotes diet-induced hepatic inflammation with features of human NASH resulting in rapid severe fibrosis and provide a novel link between regulatory processes of intestinal cholesterol and progression of fatty liver. The current study highlights the role of overactivation of intestinal SREBP-2 transcription factor in the progression of hepatic fibrosis associated with diet-induced NASH. Mice with intestine-specific overexpression of SREBP-2 demonstrated more inflammation and severe fibrosis in the liver in response to 15 wk of being fed a high-cholesterol, high-fat diet as compared with their wild-type littermates. These data demonstrate a novel link between intestinal regulatory processes of cholesterol metabolism and the pathogenesis of fatty liver diseases.
非酒精性脂肪性肝病(NAFLD)的特征是肝脏中脂质蓄积,可能进展为肝纤维化和非酒精性脂肪性肝炎(NASH)。NAFLD和NASH的潜在机制尚未完全明确。最近研究表明,膳食胆固醇是NASH发生发展的一个危险因素,提示肠道对胆固醇的处理具有一定作用。胆固醇稳态的一个重要调节因子是固醇调节元件结合蛋白2(SREBP-2)转录因子。我们检验了以下假设:肠道SREBP-2过度激活会增加对饮食诱导的NASH的易感性。使用了由绒毛蛋白启动子驱动的具有肠道特异性活性SREBP-2过表达的转基因小鼠模型(ISR2小鼠)。将ISR2小鼠及其野生型同窝小鼠喂食常规饲料或高脂高胆固醇(HFHC)饲料(15%脂肪,1%胆固醇)15周。结果显示,给ISR2小鼠喂食HFHC饲料会导致肝脏炎症,促炎细胞因子水平升高。组织学检查表明,与野生型同窝小鼠相比,ISR2小鼠在食用HFHC饲料后出现广泛纤维化,伴有血管周围和细胞周围胶原沉积。与野生型同窝小鼠相比,HFHC喂养后,ISR2小鼠肝脏中严重的炎症和进展性纤维化与脂质蓄积差异无关。这些数据表明,肠道SREBP2过度激活会促进饮食诱导的具有人类NASH特征的肝脏炎症,导致快速严重纤维化,并在肠道胆固醇调节过程与脂肪肝进展之间建立了新的联系。当前研究突出了肠道SREBP-2转录因子过度激活在与饮食诱导的NASH相关的肝纤维化进展中的作用。与野生型同窝小鼠相比,具有肠道特异性SREBP-2过表达的小鼠在喂食高胆固醇、高脂肪饮食15周后,肝脏出现了更多炎症和严重纤维化。这些数据证明了肠道胆固醇代谢调节过程与脂肪性肝病发病机制之间的新联系。